The chemical class designated as SPINK2 Inhibitors comprises various compounds that can indirectly affect the function of SPINK2. SPINK2 is a member of the serine protease inhibitor family and plays a role in regulating protease activity within certain biological processes. The inhibitors listed above are not specific antagonists of SPINK2 but influence the proteolytic environment in which SPINK2 operates. The primary mode of action of these compounds involves the inhibition of proteolytic enzymes that interact with or are regulated by SPINK2. For instance, compounds such as Gabexate Mesilate, Nafamostat Mesilate, Aprotinin, and Camostat Mesilate are known as serine protease inhibitors. Their function in inhibiting serine proteases can lead to a shift in the protease-inhibitor balance, which can indirectly impact the regulatory role of SPINK2 within these pathways. Similarly, E-64, an irreversible inhibitor of cysteine proteases, and Phenylmethylsulfonyl Fluoride, a broad-spectrum serine protease inhibitor, can modify the protease profile within the cell, potentially leading to an indirect influence on SPINK2's activity.
Other inhibitors, such as Leupeptin, AEBSF, Antipain, and Chymostatin, target thiol proteases and chymotrypsin-like proteases, respectively. Their inhibitory action can result in altered protease activity, which may affect the functional dynamics of SPINK2. Pepstatin A specifically inhibits aspartic proteases, while 3,4-Dichloroisocoumarin is a broad-spectrum serine protease inhibitor. These compounds can induce changes in the proteolytic environment that SPINK2 is involved in, thereby influencing its regulatory actions. While these chemicals offer an indirect approach to modulating SPINK2, they function by targeting the proteolytic enzymes that interact with or are controlled by SPINK2, leading to potential alterations in its biological role. These inhibitors thereby represent a diverse approach to influencing SPINK2's activity through modulation of the cellular protease activities.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A serine protease inhibitor that can indirectly affect SPINK2 by altering protease activity in related pathways. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $80.00 $300.00 | 4 | |
Another serine protease inhibitor which may influence the protease-protease inhibitor balance, potentially affecting SPINK2's role. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $110.00 $400.00 $1615.00 | 51 | |
A protease inhibitor that might alter the proteolytic environment and indirectly modulate SPINK2 activity. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $42.00 $179.00 $306.00 $612.00 $2040.00 $4386.00 | 5 | |
Inhibits serine proteases and could affect SPINK2's interaction with its targets. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
An irreversible cysteine protease inhibitor that can change the protease environment, possibly influencing SPINK2 indirectly. | ||||||
Phenylmethylsulfonyl Fluoride | 329-98-6 | sc-3597 sc-3597A | 1 g 100 g | $50.00 $683.00 | 92 | |
A serine protease inhibitor that could alter the activity of proteases that interact with SPINK2. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $72.00 $145.00 $265.00 $489.00 $1399.00 $99.00 | 19 | |
A thiol protease inhibitor that may affect the balance of proteases and indirectly impact SPINK2 function. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $50.00 $120.00 $420.00 $834.00 $1836.00 $4896.00 | 33 | |
A serine protease inhibitor that could modify the proteolytic profile and indirectly affect SPINK2. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $153.00 $255.00 $627.00 $1163.00 $2225.00 | 3 | |
A chymotrypsin-like protease inhibitor, potentially modifying the proteolytic pathways associated with SPINK2. | ||||||